Live

Mitochondria, potential new therapeutic targets in pancreatic cancer - CRCM PhD Day 2021 will take place on May 28 2021 - La cycline A2, qui maintient l'homéostasie du côlon, est un facteur de pronostic dans le cancer colorectal -

Dec Nov 2008 Journal of veterinary internal medicine

Masitinib is safe and effective for the treatment of canine mast cell tumors.

Authors

Hahn KA, Ogilvie G, Oglivie G, Rusk T, Devauchelle P, Legendre A, Powers B, Leventhal PS, Kinet JP, Palmerini F, Dubreuil P, Moussy A, Hermine O

Summary

Activation of the KIT receptor tyrosine kinase is associated with the development of canine mast cell tumors (MCT).

Read the article